| Intensity of renal support in critically ill patients with acute kidney injury VA/NIH Acute Renal Failure Trial Network New England Journal of Medicine 359 (1), 7-20, 2008 | 2167 | 2008 |
| Mycophenolate mofetil treatment for primary glomerular diseases MJ Choi, JA Eustace, LF Gimenez, MG Atta, PJ Scheel, R Sothinathan, ... Kidney international 61 (3), 1098-1114, 2002 | 409 | 2002 |
| Clinical practice guideline for the management of chronic kidney disease in patients infected with HIV: 2014 update by the HIV Medicine Association of the Infectious Diseases … GM Lucas, MJ Ross, PG Stock, MG Shlipak, CM Wyatt, SK Gupta, MG Atta, ... Clinical Infectious Diseases 59 (9), e96-e138, 2014 | 357 | 2014 |
| Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races GM Lucas, B Lau, MG Atta, DM Fine, J Keruly, RD Moore Journal of Infectious Diseases 197 (11), 1548-1557, 2008 | 265 | 2008 |
| Diabetic kidney disease: pathophysiology and therapeutic targets S Toth-Manikowski, MG Atta Journal of diabetes research 2015, 2015 | 228 | 2015 |
| Kidney disease in the setting of HIV infection: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CR Swanepoel, MG Atta, VD D’Agati, MM Estrella, AB Fogo, S Naicker, ... Kidney international 93 (3), 545-559, 2018 | 216 | 2018 |
| Antiretroviral therapy in the treatment of HIV-associated nephropathy MG Atta, JE Gallant, MH Rahman, N Nagajothi, LC Racusen, PJ Scheel, ... Nephrology Dialysis Transplantation 21 (10), 2809-2813, 2006 | 202 | 2006 |
| Primary and secondary hyperoxaluria: Understanding the enigma B Bhasin, HM Ürekli, MG Atta World journal of nephrology 4 (2), 235, 2015 | 201 | 2015 |
| Transcription of the sodium/myo-inositol cotransporter gene is regulated by multiple tonicity-responsive enhancers spread over 50 kilobase pairs in the 5′-flanking region JS Rim, MG Atta, SC Dahl, GT Berry, JS Handler, HM Kwon Journal of Biological Chemistry 273 (32), 20615-20621, 1998 | 179 | 1998 |
| Observations on a cohort of HIV-infected patients undergoing native renal biopsy AR Berliner, DM Fine, GM Lucas, MH Rahman, LC Racusen, PJ Scheel, ... American journal of nephrology 28 (3), 478-486, 2008 | 162 | 2008 |
| End-stage renal disease and chronic kidney disease in a cohort of African-American HIV-infected and at-risk HIV-seronegative participants followed between 1988 and 2004 GM Lucas, SH Mehta, MG Atta, GD Kirk, N Galai, D Vlahov, RD Moore AIDS 21 (18), 2435-2443, 2007 | 157 | 2007 |
| APOL1 risk variants predict histopathology and progression to ESRD in HIV-related kidney disease DM Fine, WG Wasser, MM Estrella, MG Atta, M Kuperman, R Shemer, ... Journal of the American Society of Nephrology 23 (2), 343-350, 2012 | 136 | 2012 |
| Clinical pharmacology in HIV therapy MG Atta, S De Seigneux, GM Lucas Clinical Journal of the American Society of Nephrology 14 (3), 435-444, 2019 | 121 | 2019 |
| Allogeneic mesenchymal stem cells for treatment of AKI after cardiac surgery M Swaminathan, M Stafford-Smith, GM Chertow, DG Warnock, ... Journal of the American Society of Nephrology 29 (1), 260-267, 2018 | 121 | 2018 |
| Renal disease in patients with HIV infection: epidemiology, pathogenesis and management DM Fine, MA Perazella, GM Lucas, MG Atta Drugs 68, 963-980, 2008 | 118 | 2008 |
| Pegunigalsidase alfa, a novel PEGylated enzyme replacement therapy for Fabry disease, provides sustained plasma concentrations and favorable pharmacodynamics: a 1‐year phase 1 … R Schiffmann, O Goker‐Alpan, M Holida, P Giraldo, L Barisoni, RB Colvin, ... Journal of inherited metabolic disease 42 (3), 534-544, 2019 | 115 | 2019 |
| Comparison of risk factors and outcomes in HIV immune complex kidney disease and HIV-associated nephropathy MC Foy, MM Estrella, GM Lucas, F Tahir, DM Fine, RD Moore, MG Atta Clinical Journal of the American Society of Nephrology 8 (9), 1524-1532, 2013 | 105 | 2013 |
| Granulomatous interstitial nephritis S Shah, N Carter-Monroe, MG Atta Clinical kidney journal 8 (5), 516-523, 2015 | 102 | 2015 |
| Kidney function and the risk of cardiovascular events in HIV-1-infected patients E George, GM Lucas, GN Nadkarni, DM Fine, R Moore, MG Atta Aids 24 (3), 387-394, 2010 | 102 | 2010 |
| Nephrotic range proteinuria and CD4 count as noninvasive indicators of HIV-associated nephropathy MG Atta, MJ Choi, JC Longenecker, M Haymart, J Wu, N Nagajothi, ... The American journal of medicine 118 (11), 1288. e21-1288. e26, 2005 | 97 | 2005 |
Gregory M. Lucas, MD PhDJohns Hopkins University School of MedicineVerified email at jhmi.edu
